Sompraz%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520hp

# Sompraz hp ## Overview Sompraz hp is a combination product containing pantoprazole, amoxicillin, and clarithromycin, used for the eradication of *Helicobacter pylori* infection. Pantoprazole is a proton pump inhibitor (PPI), and amoxicillin and clarithromycin are antibiotics. ## Primary Indications Eradication of *Helicobacter pylori* infection in patients with peptic ulcer disease. ## Adult Dosing The typical adult regimen is one packet twice daily for 7 to 14 days. Each packet contains: * Pantoprazole 40 mg * Amoxicillin 1000 mg * Clarithromycin 500 mg **Important:** Patients should take the contents of one packet twice daily, before breakfast and before the evening meal. ## Pediatric Dosing Dosing for pediatric patients is not established for this specific combination product. Treatment decisions in pediatric patients should be based on individual assessment and available guidelines for *H. pylori* eradication in this age group. ## Dose Adjustments * **Renal Impairment:** No specific dose adjustment is recommended for pantoprazole in mild to moderate renal impairment. However, caution is advised. Amoxicillin dosing may need adjustment in severe renal impairment (CrCl < 30 mL/min). Clarithromycin requires dose adjustment in patients with significant renal impairment (CrCl < 30 mL/min) – a reduced dose or extended dosing interval may be necessary. Given the fixed-dose combination, use in severe renal impairment may not be appropriate. * **Hepatic Impairment:** No dose adjustment for pantoprazole is typically required in mild to moderate hepatic impairment. However, caution is advised. Clarithromycin dose adjustment is recommended in patients with hepatic impairment, especially if concomitant renal impairment is present. The combination product may not be suitable. ## Contraindications * Hypersensitivity to pantoprazole, amoxicillin, clarithromycin, or any component of the formulation. * History of allergic reactions to penicillins or cephalosporins. * History of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use. * Contraindications to clarithromycin include concomitant use with ergotamine, cisapride, pimozide, and certain statins (simvastatin, lovastatin). * Contraindications to amoxicillin include infectious mononucleosis. ## Adverse Effects * **Common:** Diarrhea, nausea, headache, abdominal pain, rash, taste perversion. * **Less Common/Serious:** *Clostridium difficile*-associated diarrhea (CDAD), severe allergic reactions (including anaphylaxis), Stevens-Johnson syndrome, toxic epidermal necrolysis, hepatic dysfunction, QT prolongation (especially with clarithromycin), myopathy (with statins used concurrently), development of drug-resistant bacteria. ## Key Drug Interactions * **Pantoprazole:** May decrease the absorption of drugs that require gastric acidity for absorption (e.g., ketoconazole, itraconazole, digoxin). May affect the metabolism of other drugs via CYP enzymes, although less so than other PPIs. * **Amoxicillin:** May decrease the effectiveness of oral contraceptives. Probenecid can increase amoxicillin levels. * **Clarithromycin:** Potent inhibitor of CYP3A4. Significant interactions with numerous drugs including: * **CYP3A4 substrates:** Colchicine, carbamazepine, cyclosporine, tacrolimus, simvastatin, lovastatin, certain calcium channel blockers (e.g., verapamil, diltiazem), quinidine, disopyramide, midazolam, triazolam, certain anticoagulants (e.g., warfarin, rivaroxaban), theophylline. * **Other potent inhibitors of CYP3A4:** May increase clarithromycin levels. * **Drugs that prolong QT interval:** Increased risk of torsades de pointes. * **Erythromycin:** Avoid concomitant use. ## Monitoring * Assess for signs and symptoms of *H. pylori* eradication (e.g., resolution of ulcer symptoms). A urea breath test or stool antigen test is typically performed 4-8 weeks after completion of therapy. * Monitor for adverse effects, particularly diarrhea, rash, and signs of hypersensitivity. * Monitor liver function tests, especially with prolonged therapy or in patients with pre-existing hepatic disease. * Monitor renal function in patients with impaired renal function. ## Clinical Pearls * This combination therapy is designed for a specific duration and requires strict adherence to the dosing schedule for optimal efficacy and to minimize resistance. * Patients should be advised to complete the entire course of treatment, even if symptoms improve. * Probiotics may be considered to help prevent or manage diarrhea associated with antibiotic use, although evidence is variable. * Ensure adequate hydration. * Separate administration of pantoprazole from antacids by at least 2 hours. **Disclaimer:** This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant clinical guidelines for complete details, contraindications, warnings, precautions, and potential drug interactions before prescribing or dispensing any medication. Dosing and treatment regimens may vary based on local protocols and individual patient factors.